Indoor Air Purifiers for Heart Failure
Effectiveness of Indoor Air Purifiers on Heart Failure Outcomes (The PURI-HF Trial)
['FUNDING_R01'] · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · NIH-10877907
This project explores if using indoor air purifiers can help improve the health of people living with heart failure.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | NEW YORK UNIVERSITY SCHOOL OF MEDICINE (nih funded) |
| Locations | 1 site (NEW YORK, UNITED STATES) |
| Trial ID | NIH-10877907 on ClinicalTrials.gov |
What this research studies
Air pollution, especially tiny particles called PM2.5, is a major concern for heart health, particularly for those with heart failure. While some efforts have been made to reduce pollution, we still need better ways to protect our hearts. This project will explore if high-efficiency air purifiers can make a real difference in the long-term health and well-being of individuals with heart failure. We aim to understand if cleaner indoor air can lead to fewer hospital visits and better daily living for patients.
Who could benefit from this research
Good fit: Ideal candidates for this type of research would be individuals living with heart failure who are exposed to indoor air pollution.
Not a fit: Patients whose heart failure is not significantly impacted by air pollution or who do not have access to air purifiers may not directly benefit from this specific intervention.
Why it matters
Potential benefit: If successful, this work could show that using indoor air purifiers can significantly improve the health and quality of life for people with heart failure.
How similar studies have performed: While HEPA purifiers have been studied to reduce air pollution and improve some health outcomes, their long-term effects on specific heart failure outcomes are not yet fully understood, making this a novel aspect.
Where this research is happening
NEW YORK, UNITED STATES
- NEW YORK UNIVERSITY SCHOOL OF MEDICINE — NEW YORK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: VEDANTHAN, RAJESH — NEW YORK UNIVERSITY SCHOOL OF MEDICINE
- Study coordinator: VEDANTHAN, RAJESH
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Control, Cancer Control Science